Oral mesalamine at 4.8 g/d more effective than 2.4 g/d for moderately active ulcerative colitis: Commentary

Judith F. Collins

doi:10.1097/01.ebg.0000202908.45745.4f

Oral mesalamine at 4.8 g/d more effective than 2.4 g/d for moderately active ulcerative colitis: Commentary

Judith F. Collins

Gastroenterology and Hepatology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	7-8
Number of pages	2
Journal	Evidence-Based Gastroenterology
Volume	7
Issue number	1
DOIs	https://doi.org/10.1097/01.ebg.0000202908.45745.4f
State	Published - Mar 2006

ASJC Scopus subject areas

Gastroenterology

Access to Document

10.1097/01.ebg.0000202908.45745.4f

Cite this

@article{0533b508a8db4f56b4ad11712395a444,

title = "Oral mesalamine at 4.8 g/d more effective than 2.4 g/d for moderately active ulcerative colitis: Commentary",

author = "Collins, {Judith F.}",

year = "2006",

month = mar,

doi = "10.1097/01.ebg.0000202908.45745.4f",

language = "English (US)",

volume = "7",

pages = "7--8",

journal = "Evidence-Based Gastroenterology",

issn = "1527-8557",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Oral mesalamine at 4.8 g/d more effective than 2.4 g/d for moderately active ulcerative colitis

T2 - Commentary

AU - Collins, Judith F.

PY - 2006/3

Y1 - 2006/3

UR - http://www.scopus.com/inward/record.url?scp=33748154057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748154057&partnerID=8YFLogxK

U2 - 10.1097/01.ebg.0000202908.45745.4f

DO - 10.1097/01.ebg.0000202908.45745.4f

M3 - Comment/debate

AN - SCOPUS:33748154057

SN - 1527-8557

VL - 7

SP - 7

EP - 8

JO - Evidence-Based Gastroenterology

JF - Evidence-Based Gastroenterology

IS - 1

ER -

Oral mesalamine at 4.8 g/d more effective than 2.4 g/d for moderately active ulcerative colitis: Commentary

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this